Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily
| Image |  |
|---|---|
| Description | scientific article published on August 2010 |
| Author/s |
author: Hervé Dombret Jorge Eduardo Cortes Giuseppe Saglio Andreas Hochhaus Tamás Masszi |
| Publication date | August 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |